Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: Synthesis, biological evaluation and molecular modeling studies - Normandie Université Access content directly
Journal Articles European Journal of Medicinal Chemistry Year : 2008

Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: Synthesis, biological evaluation and molecular modeling studies

Dates and versions

hal-02357774 , version 1 (10-11-2019)

Identifiers

Cite

Cédric Logé, Alexandra Testard, Valérie Thiéry, Olivier Lozach, Mélina Blairvacq, et al.. Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1)/glycogen synthase kinase-3 (GSK-3) inhibitors: Synthesis, biological evaluation and molecular modeling studies. European Journal of Medicinal Chemistry, 2008, 43 (7), pp.1469-1477. ⟨10.1016/j.ejmech.2007.09.020⟩. ⟨hal-02357774⟩
22 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More